Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas.

Alkatout, Ibrahim; Friemel, Juliane; Sitek, Barbara; Anlauf, Martin; Eisenach, Patricia A; Stühler, Kai; Scarpa, Aldo; Perren, Aurel; Meyer, Helmut E; Knoefel, Wolfram T; Klöppel, Günter; Sipos, Bence (2015). Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas. Modern pathology, 28(1), pp. 69-79. Nature Publishing Group 10.1038/modpathol.2014.82

[img] Text
modpathol201482a.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (547kB) | Request a copy

The prognosis of pancreatic neuroendocrine tumors is related to size, histology and proliferation rate. However, this stratification needs to be refined further. We conducted a proteome study on insulinomas, a well-defined pancreatic neuroendocrine tumor entity, in order to identify proteins that can be used as biomarkers for malignancy. Based on a long follow-up, insulinomas were divided into those with metastases (malignant) and those without (benign). Microdissected cells from six benign and six malignant insulinomas were subjected to a procedure combining fluorescence dye saturation labeling with high-resolution two-dimensional gel electrophoresis. Differentially expressed proteins were identified using nano liquid chromatography-electrospray ionization/multi-stage mass spectrometry and validated by immunohistochemistry on tissue microarrays containing 62 insulinomas. Sixteen differentially regulated proteins were identified among 3000 protein spots. Immunohistochemical validation revealed that aldehyde dehydrogenase 1A1 and voltage-dependent anion-selective channel protein 1 showed significantly stronger expression in malignant insulinomas than in benign insulinomas, whereas tumor protein D52 (TPD52) binding protein was expressed less strongly in malignant insulinomas than in benign insulinomas. Using multivariate analysis, low TPD52 expression was identified as a strong independent prognostic factor for both recurrence-free and overall disease-related survival.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Perren, Aurel

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0893-3952

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Doris Haefelin

Date Deposited:

23 Jan 2015 15:18

Last Modified:

05 Nov 2015 13:51

Publisher DOI:

10.1038/modpathol.2014.82

PubMed ID:

24947143

BORIS DOI:

10.7892/boris.62480

URI:

https://boris.unibe.ch/id/eprint/62480

Actions (login required)

Edit item Edit item
Provide Feedback